​

Funding Round

Series A - Visen Pharmaceuticals

Series A - Visen Pharmaceuticals

Investment Firm

Overview

Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs.

Announced Date

Nov 13, 2018

Funding Type

Series A

Highlights

Location

Asia

Social

Investor Lead

Vivo Capital

Vivo Capital

Vivo Capital is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Ascendis Pharma

Ascendis Pharma

No designation

Participant Investors

3

Investor Name
Participant InvestorAscendis Pharma
Participant InvestorSofinnova Investments
Participant InvestorVivo Capital

Round Details and Background

Visen Pharmaceuticals raised $40000000 on 2018-11-13 in Series A

Visen Pharmaceuticals is a biotech company focused on developing and commercializing innovative endocrine drugs.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Jan 08, 2021
Series B - Visen Pharmaceuticals
11-150.0M
Nov 13, 2018
Series A - Visen Pharmaceuticals
3-40.0M

Recent Activity

There is no recent news or activity for this profile.